Bridgefront Capital, LLC - BIOHAVEN PHARMACTL HLDG CO L ownership

Back to all holdings Add to watchlist

BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 247 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2020. The put-call ratio across all filers is 0.72 and the average weighting 0.7%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Bridgefront Capital, LLC ownership history of BIOHAVEN PHARMACTL HLDG CO L
ValueSharesWeighting
Q2 2022$238,000
-37.7%
1,634
-58.5%
0.26%
+84.0%
Q2 2021$382,000
-57.5%
3,936
-62.4%
0.14%
-53.1%
Q4 2020$898,000–10,479–0.31%–
 Download
Other shareholders
BIOHAVEN PHARMACTL HLDG CO L shareholders Q4 2020
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 450,422$6,251,85714.11%
Liontrust Investment Partners LLP 134,659$7,478,9610.13%
Birchview Capital, LP 7,365$1020.07%
FNY Investment Advisers, LLC 250$30.00%
FNY Investment Advisers, LLC 18$00.00%
FNY Investment Advisers, LLC 56$00.00%
McElhenny Sheffield Capital Management, LLC 31$4300.00%
Blue Trust, Inc. 65$100.00%
IFP Advisors, Inc 1$10.00%
View complete list of BIOHAVEN PHARMACTL HLDG CO L shareholders